ReviewFood science & nutrition2025
The Potential of Members of the Apple Sub-Family Maloideae Against Obesity and Metabolic Disorders: A Review.
Review in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Study on the Synergistic Ultrasonic Extraction of Active Components from Loquat Leaves Using Surfactants and Their Mechanism of Action in Weight Loss and Fat Reduction.Foods (Basel, Switzerland) · 2026Article
- The Potential of Members of the Apple Sub-Family Maloideae Against Obesity and Metabolic Disorders: A Review.Food science & nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic disorder, and obesity in particular, is a global epidemic among the world's population and is a complex multifactorial health problem. Obesity is associated with serious health risks like diabetes, coronary heart disease, non-alcoholic fatty liver disease, hyperlipidemia, and hyperglycemia disorders and has shown a steady increase in morbimortality indicators. Many drugs have been approved for effective treatment of metabolic disorders and their symptoms, but the cost on the health system and on the individual patient is extremely high. Therefore, an adjunctive treatment for managing obesity and metabolic disorder could be in the use of medicinal plants and functional foods, which could reduce the cost as well as reduce the side effects of these medications. Traditional herbal medicines and functional foods have become the subject of global importance, with both medical and economic implications. The apple subfamily Maloideae includes commercially and medicinally valuable fruits like apples, pears, loquat, quince, and hawthorn, and many other plants. This subfamily has a distinctive fruit, the pome, with characteristic antioxidant content. This review summarizes the recently published research, preclinical data, brief phytochemistry, and pharmacology on 5 Maloideae genera to underscore their potential as adjunctive therapy against obesity and metabolic disorder and future research opportunities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.